Home » U.S. FDA’s Nanotech Draft Guidance Is First Step Toward Regulation
U.S. FDA’s Nanotech Draft Guidance Is First Step Toward Regulation
July 1, 2011
Outlining a “roadmap for discussion,” the U.S. Food and Drug Administration (FDA) released a draft of its nanotechnology guidance, to help industry better determine whether an FDA-regulated product uses nanotechnology.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor